1. Home
  2. GFR vs MGTX Comparison

GFR vs MGTX Comparison

Compare GFR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

N/A

Current Price

$7.73

Market Cap

924.7M

Sector

N/A

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$8.85

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFR
MGTX
Founded
2018
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
924.7M
881.7M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
GFR
MGTX
Price
$7.73
$8.85
Analyst Decision
Sell
Buy
Analyst Count
3
8
Target Price
$7.72
★ $27.75
AVG Volume (30 Days)
★ 1.6M
610.0K
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 0.68
Revenue
N/A
★ $81,391,000.00
Revenue This Year
N/A
$314.19
Revenue Next Year
$142.30
N/A
P/E Ratio
★ $4.33
$7.43
Revenue Growth
N/A
★ 144.57
52 Week Low
$4.15
$6.62
52 Week High
$7.81
$15.35

Technical Indicators

Market Signals
Indicator
GFR
MGTX
Relative Strength Index (RSI) 65.18 39.22
Support Level $5.63 $8.88
Resistance Level N/A $10.08
Average True Range (ATR) 0.23 0.50
MACD 0.14 0.09
Stochastic Oscillator 96.46 29.03

Price Performance

Historical Comparison
GFR
MGTX

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: